Andrew R. Robbins
President and CEO · Cogent Biosciences, Inc.
Individual
- 2025
- May 21, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Andrew R. Robbins files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Fairmount Funds Management LLC - $370.02M in COGT purchases and sales in the last 12 months
- John Edward Robinson - $3.49M in COGT purchases and sales in the last 12 months
- Jessica Sachs - $3.20M in COGT purchases and sales in the last 12 months
- John L. Green - $2.98M in COGT purchases and sales in the last 12 months
- Evan Kearns - $2.52M in COGT purchases and sales in the last 12 months
- Arlene Morris - $1.69M in COGT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Andrew R. Robbins?
Andrew R. Robbins is a corporate insider, tracked as President and CEO of Cogent Biosciences, Inc. (COGT). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Andrew R. Robbins last file a Form 4?
The most recent primary Form 4 on record is dated 21 May 2026, one of 2 filings going back to 2025.
